These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23282618)

  • 1. [Pharmacokinetic considerations in critically ill patients].
    Escobar L; Gai MN; Regueira T; Andresen M
    Rev Med Chil; 2012 Jun; 140(6):780-8. PubMed ID: 23282618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.
    Roberts DJ; Hall RI
    Expert Opin Drug Metab Toxicol; 2013 Sep; 9(9):1067-84. PubMed ID: 23682923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations.
    Papadopoulos J; Smithburger PL
    Crit Care Med; 2010 Jun; 38(6 Suppl):S126-35. PubMed ID: 20502166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics/pharmacodynamics of antibacterials in the Intensive Care Unit: setting appropriate dosing regimens.
    Scaglione F; Paraboni L
    Int J Antimicrob Agents; 2008 Oct; 32(4):294-301. PubMed ID: 18621508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients.
    Hites M; Dell'Anna AM; Scolletta S; Taccone FS
    Adv Drug Deliv Rev; 2014 Nov; 77():12-21. PubMed ID: 24842474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of risk factors of prolonged intensive care unit stay of critically ill obstetric patients: a 5-year retrospective review in 3 hospitals in Beijing].
    Lin Y; Zhu X; Liu F; Zhao YY; Du J; Yao GQ; Li WX; Jia XJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Aug; 23(8):449-53. PubMed ID: 21878165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A view from the other side.
    Levy MM
    Crit Care Med; 2007 Feb; 35(2):603-4. PubMed ID: 17205006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
    Czock D; Hüsig-Linde C; Langhoff A; Schöpke T; Hafer C; de Groot K; Swoboda S; Kuse E; Haller H; Fliser D; Keller F; Kielstein JT
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1263-8. PubMed ID: 17699357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered pharmacology in the Intensive Care Unit patient.
    Zagli G; Tarantini F; Bonizzoli M; Di Filippo A; Peris A; De Gaudio AR; Geppetti P
    Fundam Clin Pharmacol; 2008 Oct; 22(5):493-501. PubMed ID: 18684127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of comorbid [corrected] conditions on critical illness.
    Esper AM; Martin GS
    Crit Care Med; 2011 Dec; 39(12):2728-35. PubMed ID: 22094497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation.
    Jamal JA; Economou CJ; Lipman J; Roberts JA
    Curr Opin Crit Care; 2012 Oct; 18(5):460-71. PubMed ID: 22820155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of critically ill patients in ICUs in mainland China.
    Du B; An Y; Kang Y; Yu X; Zhao M; Ma X; Ai Y; Xu Y; Wang Y; Qian C; Wu D; Sun R; Li S; Hu Z; Cao X; Zhou F; Jiang L; Lin J; Chen E; Qin T; He Z; Zhou L;
    Crit Care Med; 2013 Jan; 41(1):84-92. PubMed ID: 23222268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of meropenem in critically ill patients with severe infections.
    Binder L; Schwörer H; Hoppe S; Streit F; Neumann S; Beckmann A; Wachter R; Oellerich M; Walson PD
    Ther Drug Monit; 2013 Feb; 35(1):63-70. PubMed ID: 23318279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to optimise antimicrobial prescriptions in the Intensive Care Unit: principles of individualised dosing using pharmacokinetics and pharmacodynamics.
    Roberts JA; Joynt GM; Choi GY; Gomersall CD; Lipman J
    Int J Antimicrob Agents; 2012 Mar; 39(3):187-92. PubMed ID: 22226651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
    Varghese JM; Roberts JA; Lipman J
    Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-traumatic stress disorder in somatic disease: lessons from critically ill patients.
    Schelling G
    Prog Brain Res; 2008; 167():229-37. PubMed ID: 18037018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal doripenem dosing simulations in critically ill nosocomial pneumonia patients with obesity, augmented renal clearance, and decreased bacterial susceptibility.
    Roberts JA; Lipman J
    Crit Care Med; 2013 Feb; 41(2):489-95. PubMed ID: 23263583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug events in intensive care units: risk factors, impact, and the role of team care.
    Kane-Gill SL; Jacobi J; Rothschild JM
    Crit Care Med; 2010 Jun; 38(6 Suppl):S83-9. PubMed ID: 20502179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug dosing considerations for the critically ill patient with liver disease.
    Lin S; Smith BS
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):335-40. PubMed ID: 20691384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.